Bevespi Aerosphere

Bevespi Aerosphere treats COPD including chronic bronchitis and/or emphysema.

Bevespi Aerosphere Overview

Reviewed: May 2, 2016
Updated: 

Bevespi Aerosphere is a prescription medication used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Bevespi Aerosphere is a single product containing 2 products:glycopyrrolate and formoterol fumarate.

Glycopyrrolate belongs to a group of drugs called anticholinergics. Formoterol fumarate belongs to a group of drugs called long-acting beta agonists (LABAs). Together these work to make it easier to breathe, because they help relax the muscles around the airways in your lungs. 

This medication is available as an inhalation and is typically used twice a day. 

Common side effects of Bevespi Aerosphere include urinary tract infection and cough.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Manufacturer

Back to Top

Generic

Back to Top

Glycopyrrolate and formoterol fumarate

For more information on this medication choose from the list of selections below.

Bevespi Aerosphere Drug Class

Back to Top

Bevespi Aerosphere is part of the drug class: